Summary of seroprotection and seronconversion rates—Pre-dose 1 and post-dose 3 (PPAS).
PERTUSSIS
n refers to the number of subjects experiencing the endpoint listed in the first three columns; M refers to the number of subjects with available data for the relevant endpoint; *Vaccine response is defined as: If the pre-primary vaccination concentration is < 4 x LLOQ, then the post-primary vaccination concentration is ≥ 4 x LLOQ; If the pre-primary vaccination concentration is ≥ 4 x LLOQ, then the post-primary vaccination concentration is ≥ the pre-primary concentration; LLOQ is 2 EU/mL for pertussis antigens for DTP-ECL assay.